{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:42:33Z","timestamp":1782826953594,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014569","name":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.farma.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T02:09:05Z","timestamp":1734228545000},"page":"T179-T183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["[Translated article] National survey and consensus document on dosing strategies for beta-lactam antibiotics against multidrug-resistant gram-negative bacilli (MDR-GNB) in critically ill patients undergoing extracorporeal life-support techniques: The DOSEBL study protocol"],"prefix":"10.1016","volume":"49","author":[{"given":"Alba","family":"Pau-Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"N\u00fa\u00f1ez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Sadyrbaeva-Dolgova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dom\u00e9nech Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Campelo S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor del Mar","family":"Peria\u00f1ez Parraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Saeed Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f2nia","family":"Luque Pardos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.farma.2024.11.005_bb0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.medin.2021.12.002","article-title":"The problem of multi-resistance in gram-negative bacilli in intensive care units: treatment and prevention strategies","volume":"46","author":"Garnacho-Montero","year":"2022","journal-title":"Med Intensiva."},{"issue":"11","key":"10.1016\/j.farma.2024.11.005_bb0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.farma.2024.11.005_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","article-title":"Pharmacokinetic alterations associated with critical illness","volume":"62","author":"Morales Castro","year":"2023","journal-title":"Clin Pharmacokinet."},{"issue":"9","key":"10.1016\/j.farma.2024.11.005_bb0020","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2016.07.169","article-title":"Pharmacokinetics and dosing of anti-infective drugs in patients on extracorporeal membrane oxygenation: a review of the current literature","volume":"38","author":"Sherwin","year":"2016","journal-title":"Clin Ther."},{"issue":"3","key":"10.1016\/j.farma.2024.11.005_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/antibiotics11030338","article-title":"Antibiotics and ECMO in the adult population\u2014persistent challenges and practical guides","volume":"11","author":"Gomez","year":"2022","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.farma.2024.11.005_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.202207-1393OC","article-title":"Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation","volume":"207","author":"Shekar","year":"2023","journal-title":"Am J Respir Crit Care Med."},{"issue":"8","key":"10.1016\/j.farma.2024.11.005_bb0035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","article-title":"The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal replacement therapy study","volume":"72","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis."},{"issue":"23","key":"10.1016\/j.farma.2024.11.005_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11236898","volume":"11","author":"Bakdach","year":"2022","journal-title":"J Clin Med."},{"issue":"1","key":"10.1016\/j.farma.2024.11.005_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FTD.0000000000000941","article-title":"Therapeutic drug monitoring of antibiotic drugs in patients receiving continuous renal replacement therapy or intermittent hemodialysis: a critical review","volume":"44","author":"Matusik","year":"2022","journal-title":"Ther Drug Monit."},{"issue":"1","key":"10.1016\/j.farma.2024.11.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03397-1","article-title":"Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study","volume":"24","author":"K\u00fchn","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.farma.2024.11.005_bb0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17512433.2021.1901574","article-title":"Pharmacokinetic\/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams\/beta-lactamase inhibitors","volume":"14","author":"Gatti","year":"2021","journal-title":"Exp Rev Clin Pharmacol."},{"issue":"3","key":"10.1016\/j.farma.2024.11.005_bb0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/antibiotics12030568","article-title":"Update on therapeutic drug monitoring of beta-lactam antibiotics in critically ill patients\u2014a narrative review","volume":"12","author":"Sta\u0161ek","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.farma.2024.11.005_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients - guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique - SFPT) and the French Society of Anesthesia","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.farma.2024.11.005_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1214\/aoms\/1177705148","article-title":"Snowball sampling","volume":"32","author":"Goodman","year":"1961","journal-title":"Ann Math Stat."},{"issue":"1","key":"10.1016\/j.farma.2024.11.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med."},{"key":"10.1016\/j.farma.2024.11.005_bb0080","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.farma.2024.11.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.091716","article-title":"Development of the AGREE II, part 2: assessment of validity of items and tools to support application","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.farma.2024.11.005_bb0090","first-page":"8","article-title":"Delphi technique theoretical framework in qualitative research","volume":"3","author":"Habibi","year":"2014","journal-title":"Int J Eng Sci."},{"issue":"10","key":"10.1016\/j.farma.2024.11.005_bb0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00134-022-06847-2","article-title":"Machines that help machines to help patients: optimizing antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software","volume":"48","author":"Roberts","year":"2022","journal-title":"Intensive Care Med."}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634324001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634324001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:18:36Z","timestamp":1746757116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634324001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1130634324001880"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2024.11.005","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] National survey and consensus document on dosing strategies for beta-lactam antibiotics against multidrug-resistant gram-negative bacilli (MDR-GNB) in critically ill patients undergoing extracorporeal life-support techniques: The DOSEBL study protocol","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.07.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}